Project Grant R56HL175627
Award Date
9/17/24
Completion Date
8/31/25
Dollars Obligated
$754K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), has awarded a $742,395 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Case Western Reserve University to develop and validate a machine learning-based risk prediction model for heart failure using coronary artery calcium scans. The project aims to leverage the large patient populations from the University Hospitals CLARIFY and Houston Methodist HeartScan programs, as well as...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), awarded a $299,604 Project Grant (R01HL177813) to Case Western Reserve University (CWRU) to develop and validate a novel "Transfer Volume Regression" method to enable quantitative clinical risk predictions for major cardiovascular events, including stroke, heart attack, heart failure, and death. The 4-year project aims to create a smart, standardized,...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $104,933 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Duke University to determine the role of age-related clonal hematopoiesis of indeterminate potential (CHIP), an inflammatory biomarker, in cardiorespiratory fitness (CRF) and cardiometabolic responses to chronic exercise interventions. The project aims to (1) evaluate if CHIP is associated with worse baseline CRF and predicts heterogeneity in response to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), is for a research project titled "Artificial Intelligence Imaging Biomarkers of Longitudinal Cardiovascular Stress." The $1,526,628 award, effective from December 12, 2024 to January 31, 2025, will fund the development and validation of artificial intelligence (AI) models to predict biological cardiovascular age from...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $243,000 project grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Cincinnati. The 2-year award, spanning January 1, 2025 to December 31, 2026, aims to engineer novel RNA biodevices that integrate CRISPR and ADAR gene-editing technologies. This innovative approach seeks to enhance the efficiency and specificity of converting cardiac...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $641,544 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of North Carolina at Chapel Hill (UNC-CH). The funding will support a 4-year research project focused on developing enhanced machine learning tools to analyze complex biomedical data related to heart, lung, blood, and sleep (HLBS) disorders. Specifically, the project aims to: 1) propose novel machine learning methods for...
This $815,510 Project Grant awarded by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to develop a genetic-based classifier that can predict cancer patients' susceptibility to drug-induced cardiovascular toxicity. The University of Chicago, the prime awardee, will use a novel system of cardiac guided differentiation cultures and single-cell RNA sequencing to study the effects of three anticancer drugs...
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $752,495 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Connecticut. The grant's objective is to develop a deep learning-based algorithm to remove cardiopulmonary resuscitation (CPR) artifacts from electrocardiogram (ECG) signals, enabling continuous CPR and accurate shock decisions during out-of-hospital cardiac arrest...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $121,500 Project Grant to The University of Texas MD Anderson Cancer Center. The 2-year grant, effective from September 1, 2024 to August 31, 2026, will support research to investigate the molecular mechanisms by which environmental and lifestyle risk factors influence cardiovascular traits and disease risk. The research will leverage multi-omics data from the...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $827,665 to the New York Genome Center, Inc. (NYGC) for research to address key challenges in cardiovascular disease (CVD) genetics. The project aims to develop scalable methods to identify causal genetic variants, determine relevant cell types, and map target genes modulated by CVD variants. Key activities include: 1)...